Tempus Ai Cl A (TEM)

$51.29 +4.12 (8.73%)
Market Cap 8.47B
Revenue (ttm) 1.27B
Net Income (ttm) -245.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.27%
Debt to Equity Ratio 0.73
Volume 10,380,899
Avg Vol 5,639,124
Day's Range N/A - N/A
Shares Out 179.57M
Stochastic %K 92%
Beta 3.99
Analysts Sell
Price Target $66.53

Company Profile

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 976 5448
Fax: 800 893 0276
Address:
600 West Chicago Avenue, Suite 510, Chicago, United States
MissionImpossibl
MissionImpossibl May. 29 at 3:55 PM
$TEM remember this is blue stock !! Just bought with the FDA news .. 🗞️ hope reds also love it soon !! 🥰
0 · Reply
AStrokeOfLuck
AStrokeOfLuck May. 29 at 3:30 PM
$TEM
0 · Reply
Alican1994
Alican1994 May. 29 at 3:14 PM
$TEM stock experts are you still here 🤣
1 · Reply
2MuchWinning
2MuchWinning May. 29 at 2:48 PM
$FLNC $EOSE $SYM $TEM Bulltardios having an awesome weekend lmao imbeciles
0 · Reply
Digitcipher
Digitcipher May. 29 at 2:38 PM
$FLNC $EOSE $SYM $TEM Nobody cares about you 🤡🤡🤡
1 · Reply
NewbeeTrader111
NewbeeTrader111 May. 29 at 2:38 PM
$TEM sold 200 weekly $45 puts for 4 cents each , for some me free money on Friday
0 · Reply
Alican1994
Alican1994 May. 29 at 2:35 PM
$TEM Wait too many peste a culo here and negative putitas 😉
0 · Reply
Alican1994
Alican1994 May. 29 at 2:34 PM
$TEM $$$$$$$$$$
0 · Reply
SireThinkalot
SireThinkalot May. 29 at 2:31 PM
$TEM Great time to add!
0 · Reply
NotStockGuru
NotStockGuru May. 29 at 2:29 PM
$TEM With the best news, it's down 5%. Now, just imagine what would have happen if it had the smallest bad news, not big, just the smallest? 🤔
0 · Reply
Latest News on TEM
Tempus AI expects 25% top-line growth over next 3 years

2026-05-29T14:36:26.000Z - 1 hour ago

Tempus AI expects 25% top-line growth over next 3 years

Tempus AI reiterates FY26 revenue view of $1.59B-$1.6B, consensus $1.59B

2026-05-29T14:35:02.000Z - 1 hour ago

Tempus AI reiterates FY26 revenue view of $1.59B-$1.6B, consensus $1.59B

Tempus AI announces initial results from Multimodal Foundation Model efforts

2026-05-29T13:35:50.000Z - 2 hours ago

Tempus AI announces initial results from Multimodal Foundation Model efforts

Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology

May 29, 2026, 9:15 AM EDT - 2 hours ago

Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology

Tempus AI Slides: FY 2026

May 29, 2026, 9:00 AM EDT - 3 hours ago

Tempus AI Slides: FY 2026

Tempus AI receives FDA approval for tumor-only xT CDx

2026-05-29T12:52:31.000Z - 3 hours ago

Tempus AI receives FDA approval for tumor-only xT CDx

Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio

May 29, 2026, 8:15 AM EDT - 3 hours ago

Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio

Tempus AI announces expansion of indications to Next platform

2026-05-28T15:53:27.000Z - 1 day ago

Tempus AI announces expansion of indications to Next platform

Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

May 28, 2026, 8:30 AM EDT - 1 day ago

Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

Tempus AI announces upgrade to Tempus Hub

2026-05-27T13:28:05.000Z - 2 days ago

Tempus AI announces upgrade to Tempus Hub

Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows

May 27, 2026, 8:33 AM EDT - 2 days ago

Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

May 26, 2026, 8:30 AM EDT - 3 days ago

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Tempus AI announces clinical launch of ArteraAI Prostate Test

2026-05-21T12:47:44.000Z - 8 days ago

Tempus AI announces clinical launch of ArteraAI Prostate Test

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

May 21, 2026, 8:30 AM EDT - 8 days ago

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

Tempus AI announces strategic collaboration with Bristol Myers

2026-05-14T15:30:17.000Z - 15 days ago

Tempus AI announces strategic collaboration with Bristol Myers

BMY

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

May 14, 2026, 8:30 AM EDT - 15 days ago

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

BMY

Cathie Wood’s ARK Investment buys 163K shares of Tempus AI today

2026-05-12T00:05:13.000Z - 17 days ago

Cathie Wood’s ARK Investment buys 163K shares of Tempus AI today

Tempus AI price target lowered to $64 from $95 at H.C. Wainwright

2026-05-11T10:22:34.000Z - 18 days ago

Tempus AI price target lowered to $64 from $95 at H.C. Wainwright

Ambry Genetics' CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

May 11, 2026, 6:00 AM EDT - 18 days ago

Ambry Genetics' CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

Tempus AI price target lowered to $80 from $90 at BTIG

2026-05-10T14:10:04.000Z - 19 days ago

Tempus AI price target lowered to $80 from $90 at BTIG

Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes

May 8, 2026, 12:59 AM EDT - 21 days ago

Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes

Tempus AI announces proposed convertible senior notes offering

2026-05-07T14:10:10.000Z - 22 days ago

Tempus AI announces proposed convertible senior notes offering

Cathie Wood’s ARK Investment buys 146K shares of Tempus AI today

2026-05-07T12:30:22.000Z - 22 days ago

Cathie Wood’s ARK Investment buys 146K shares of Tempus AI today

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

May 7, 2026, 7:11 AM EDT - 22 days ago

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Tempus AI price target lowered to $59 from $68 at Baird

2026-05-07T09:05:35.000Z - 22 days ago

Tempus AI price target lowered to $59 from $68 at Baird

Tempus AI price target raised to $68 from $65 at TD Cowen

2026-05-07T06:36:13.000Z - 22 days ago

Tempus AI price target raised to $68 from $65 at TD Cowen

Lucent Diagnostics announces collaboration with Tempus AI

2026-05-07T06:21:33.000Z - 22 days ago

Lucent Diagnostics announces collaboration with Tempus AI

QTRX

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

May 6, 2026, 8:00 AM EDT - 23 days ago

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

QTRX

Tempus AI reports Q1 adjusted EPS (13c), consensus (20c)

2026-05-05T20:35:01.000Z - 23 days ago

Tempus AI reports Q1 adjusted EPS (13c), consensus (20c)

Tempus AI raises FY26 revenue view to $1.59B-$1.6B from $1.59B, consensus $1.59B

2026-05-05T20:33:33.000Z - 23 days ago

Tempus AI raises FY26 revenue view to $1.59B-$1.6B from $1.59B, consensus $1.59B

Tempus AI Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 23 days ago

Tempus AI Earnings Call Transcript: Q1 2026

Tempus AI Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 23 days ago

Tempus AI Earnings release: Q1 2026

Tempus AI Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 23 days ago

Tempus AI Slides: Q1 2026

Tempus AI Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 23 days ago

Tempus AI Quarterly report: Q1 2026

Tempus Reports First Quarter 2026 Results

May 5, 2026, 4:01 PM EDT - 23 days ago

Tempus Reports First Quarter 2026 Results

Tempus to Host Inaugural Investor Day on May 29, 2026

Apr 29, 2026, 8:30 AM EDT - 4 weeks ago

Tempus to Host Inaugural Investor Day on May 29, 2026

Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Apr 28, 2026, 8:30 AM EDT - 4 weeks ago

Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Apr 23, 2026, 8:30 AM EDT - 5 weeks ago

Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Tempus to Report First Quarter 2026 Financial Results on May 5

Apr 21, 2026, 8:30 AM EDT - 5 weeks ago

Tempus to Report First Quarter 2026 Financial Results on May 5

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

Apr 15, 2026, 8:30 AM EDT - 6 weeks ago

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

Tempus AI Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 14, 2026, 11:45 AM EDT - 6 weeks ago

Tempus AI Transcript: 25th Annual Needham Virtual Healthcare Conference

Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

Apr 14, 2026, 8:30 AM EDT - 6 weeks ago

Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care

Apr 13, 2026, 8:30 AM EDT - 6 weeks ago

Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

Apr 9, 2026, 8:30 AM EDT - 7 weeks ago

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

GILD

Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 4:01 PM EDT - 7 weeks ago

Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Tempus AI Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 7 weeks ago

Tempus AI Proxy statement: Proxy filing

Tempus AI Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 7 weeks ago

Tempus AI Proxy statement: Proxy filing

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

Apr 1, 2026, 8:30 AM EDT - 2 months ago

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Mar 17, 2026, 8:30 AM EDT - 2 months ago

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Mar 11, 2026, 8:30 AM EDT - 2 months ago

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Tempus AI Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Mar 3, 2026, 12:15 PM EST - 3 months ago

Tempus AI Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Mar 3, 2026, 8:30 AM EST - 3 months ago

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound

Feb 27, 2026, 7:24 PM EST - 3 months ago

After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Feb 26, 2026, 8:30 AM EST - 3 months ago

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building

Feb 25, 2026, 6:23 PM EST - 3 months ago

Tempus AI Sold Off After a Beat—But the Rebound Case Is Building

Tempus AI Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 3 months ago

Tempus AI Earnings Call Transcript: Q4 2025

Tempus AI Annual report: Q4 2025

Feb 24, 2026, 4:30 PM EST - 3 months ago

Tempus AI Annual report: Q4 2025

Tempus AI Earnings release: Q4 2025

Feb 24, 2026, 4:30 PM EST - 3 months ago

Tempus AI Earnings release: Q4 2025

Tempus AI Slides: Q4 2025

Feb 24, 2026, 4:30 PM EST - 3 months ago

Tempus AI Slides: Q4 2025

Tempus Reports Fourth Quarter and Full Year 2025 Results

Feb 24, 2026, 4:01 PM EST - 3 months ago

Tempus Reports Fourth Quarter and Full Year 2025 Results

Is TEM Stock A Buy At $60?

Feb 19, 2026, 11:01 AM EST - 3 months ago

Is TEM Stock A Buy At $60?

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Feb 18, 2026, 8:30 AM EST - 3 months ago

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

Feb 12, 2026, 4:05 PM EST - 3 months ago

Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform

Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States

Feb 12, 2026, 4:05 PM EST - 3 months ago

Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

Feb 10, 2026, 8:30 AM EST - 3 months ago

Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

Ambry's Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

Feb 4, 2026, 7:00 AM EST - 4 months ago

Ambry's Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

Feb 2, 2026, 7:00 AM EST - 4 months ago

Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Jan 27, 2026, 8:30 AM EST - 4 months ago

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers

Tempus Logix Launches AI-Powered Calculator to End Hidden Fees and Price Fluctuation in Auto Transport

Jan 26, 2026, 11:14 AM EST - 4 months ago

Tempus Logix Launches AI-Powered Calculator to End Hidden Fees and Price Fluctuation in Auto Transport

Tempus Announces the Launch of Paige Predict

Jan 21, 2026, 8:30 AM EST - 4 months ago

Tempus Announces the Launch of Paige Predict

Tempus AI Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 4:30 PM EST - 4 months ago

Tempus AI Transcript: 44th Annual J.P. Morgan Healthcare Conference

Tempus AI Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 4:30 PM EST - 4 months ago

Tempus AI Slides: 44th Annual J.P. Morgan Healthcare Conference

Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Jan 12, 2026, 8:30 AM EST - 4 months ago

Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology

Here's why the Tempus AI stock may surge 47% soon

Jan 12, 2026, 8:00 AM EST - 4 months ago

Here's why the Tempus AI stock may surge 47% soon

Northwestern Medicine Selects Tempus to Expand Genomic Testing

Jan 12, 2026, 7:00 AM EST - 4 months ago

Northwestern Medicine Selects Tempus to Expand Genomic Testing

Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion

Jan 11, 2026, 5:30 PM EST - 4 months ago

Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion

Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results

Jan 11, 2026, 5:00 PM EST - 4 months ago

Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results

Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

Jan 8, 2026, 8:30 AM EST - 5 months ago

Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

Rune Labs Taps Tempus Exec as New CEO to Expand AI-Enabled Neurology Care

Jan 8, 2026, 8:15 AM EST - 5 months ago

Rune Labs Taps Tempus Exec as New CEO to Expand AI-Enabled Neurology Care

Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 8:30 AM EST - 5 months ago

Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference

Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium

Dec 9, 2025, 8:30 AM EST - 6 months ago

Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium

Tempus AI Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 10:30 AM EST - 6 months ago

Tempus AI Transcript: Piper Sandler 37th Annual Healthcare Conference

Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 8:30 AM EST - 6 months ago

Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Nov 14, 2025, 8:30 AM EST - 7 months ago

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

MissionImpossibl
MissionImpossibl May. 29 at 3:55 PM
$TEM remember this is blue stock !! Just bought with the FDA news .. 🗞️ hope reds also love it soon !! 🥰
0 · Reply
AStrokeOfLuck
AStrokeOfLuck May. 29 at 3:30 PM
$TEM
0 · Reply
Alican1994
Alican1994 May. 29 at 3:14 PM
$TEM stock experts are you still here 🤣
1 · Reply
2MuchWinning
2MuchWinning May. 29 at 2:48 PM
$FLNC $EOSE $SYM $TEM Bulltardios having an awesome weekend lmao imbeciles
0 · Reply
Digitcipher
Digitcipher May. 29 at 2:38 PM
$FLNC $EOSE $SYM $TEM Nobody cares about you 🤡🤡🤡
1 · Reply
NewbeeTrader111
NewbeeTrader111 May. 29 at 2:38 PM
$TEM sold 200 weekly $45 puts for 4 cents each , for some me free money on Friday
0 · Reply
Alican1994
Alican1994 May. 29 at 2:35 PM
$TEM Wait too many peste a culo here and negative putitas 😉
0 · Reply
Alican1994
Alican1994 May. 29 at 2:34 PM
$TEM $$$$$$$$$$
0 · Reply
SireThinkalot
SireThinkalot May. 29 at 2:31 PM
$TEM Great time to add!
0 · Reply
NotStockGuru
NotStockGuru May. 29 at 2:29 PM
$TEM With the best news, it's down 5%. Now, just imagine what would have happen if it had the smallest bad news, not big, just the smallest? 🤔
0 · Reply
mikesterz7
mikesterz7 May. 29 at 2:27 PM
$TEM 🚨🚨🚨 Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio
0 · Reply
Xliao38890
Xliao38890 May. 29 at 2:27 PM
$TEM it’s traded like a bio stock ….
0 · Reply
2MuchWinning
2MuchWinning May. 29 at 2:27 PM
$FLNC $EOSE $SYM $TEM bulltardios attacking me for being short the easiest SHORTS of this bubble. your losses, my gains muahahhahahahahha friday is payday, BEARS in control. REDRUMMMMMMMMM
0 · Reply
PAYMECASHMONEY
PAYMECASHMONEY May. 29 at 2:24 PM
$TEM now down 20% YTD ouch
0 · Reply
NotStockGuru
NotStockGuru May. 29 at 2:23 PM
$TEM I hope you have a screenshot of that $55 because it was the last time you'll ever see this trash again in that price range.
0 · Reply
FullTrust
FullTrust May. 29 at 2:23 PM
$TEM point to where this stock hurt me
0 · Reply
JazzEnthusiast
JazzEnthusiast May. 29 at 2:21 PM
$TEM this getting sold off today is one of the most insane moves ive ever seen. this should be up 50%
0 · Reply
Farorm
Farorm May. 29 at 2:21 PM
$TEM yes, FDA approval is usually really bearish!!
0 · Reply
Xliao38890
Xliao38890 May. 29 at 2:21 PM
$TEM maybe, the findings are not favorable
0 · Reply
william2012
william2012 May. 29 at 2:21 PM
$TEM damn do
0 · Reply
PAYMECASHMONEY
PAYMECASHMONEY May. 29 at 2:20 PM
$TEM wow 10% drop in an hour is brutal
0 · Reply
Sonnywasright1
Sonnywasright1 May. 29 at 2:19 PM
$TEM FDA approval should take this down to 35$ lol
1 · Reply